Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-070600

Director acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hallal David · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-06 Grant or award : show line 1 in the form +35,000 2,143,662 D
Loading xslF345X05/ownership.xml…